Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Vaccine shortage Stories

2005-08-31 09:00:00

NEW YORK (Reuters) - Chiron Corp., which last year suspended U.S. sales of its flu vaccine because of contamination problems at its plant in England, on Wednesday said it hopes to supply the vaccine in the 2005-2006 flu season following a favorable inspection of the plant by U.S. regulators. The U.S.-based company's manufacturing license for its Fluvirin vaccine was withdrawn last October because of contamination problems at the factory in Liverpool, depriving the United States of almost half...

2005-08-31 08:45:00

NEW YORK -- Chiron Corp., which last year suspended U.S. sales of its flu vaccine because of contamination problems at its plant in England, on Wednesday said it hopes to supply the vaccine in the 2005-2006 flu season following a recent favorable inspection of the plant by U.S. regulators. The U.S.-based company's manufacturing license for its Fluvirin vaccine was withdrawn last October because of contamination problems at the factory in Liverpool, depriving the United States of almost half...

2005-07-20 14:23:36

CHICAGO (Reuters) - Troubled flu vaccine maker Chiron Corp. on Wednesday said it is unable to supply a German-made flu vaccine in key European markets for the 2005-2006 season, days after reporting it would slash production due to potential contamination at a German plant. Chiron said it will not be able to make its Begrivac flu vaccine, sold in Germany and the U.K., after last week saying it would cut production by two-thirds and possibly delay shipments due to problems with plant...

2005-07-15 08:39:13

CHICAGO (Reuters) - Chiron Corp., which scrapped its flu vaccine last season because of contamination problems, on Friday warned it will cut supplies to non-U.S. markets this year due to plant issues in Germany. Chiron warned that production of its German-made Begrivac flu vaccine will be sharply scaled back due to sterility problems, and said it is working with U.S. regulators to restore production of its Fluvirin vaccine made at a British plant. The stock fell 2.5 percent in early...

2005-07-15 09:35:00

CHICAGO -- Chiron Corp., which scrapped its flu vaccine last season because of contamination problems, on Friday warned it will cut supplies to non-U.S. markets this year due to plant issues in Germany. Chiron warned that production of its German-made Begrivac flu vaccine will be sharply scaled back due to sterility problems, and said it is working with U.S. regulators to restore production of its Fluvirin vaccine made at a British plant. The stock fell 2.5 percent in early trade. Chiron cut...